What is Ketamine?
For decades, doctors have prescribed medication and therapy to treat depression and anxiety. Some antidepressants can take weeks to months to ease symptoms, may not be effective for everyone, and may cause unpleasant side effects. Low dose ketamine in a monitored setting can help! Numerous studies show its effectiveness as a treatment option. Ketamine therapy can significantly reduce symptoms of depression within 4 hours. Our clinic offers intravenous and intramuscular treatments, and offer therapy immediately following the session to maximize the therapeutic effect. We will soon offer intranasal treatment.
​
We are committed to utilizing the most current data and research to ensure our patients achieve the best possible outcomes, all while maintaining a safe and comfortable environment.
How does it work?
Ketamine is believed to work by increasing the neurotransmitter levels called glutamate in the brain. Glutamate is a crucial messenger for brain activity. Increasing glutamate allows the development of new neural pathways and the repair of old ones. In a clinical study, ketamine treatment was shown to have a 60-75% response rate in cases where other antidepressants failed.
​
Ketamine treatment typically involves a series of six carefully monitored treatment sessions over 2-3 weeks in an outpatient office setting.
Ketamine for Depression and Anxiety
Ketamine has anti-inflammatory properties, which may be relevant to its efficacy in the treatment of depression. Chronic inflammation has been linked to the development of depression, and ketamine may help reduce inflammation in the brain and other parts of the body.
Ketamine can increase the activity of the serotonin system, another neurotransmitter involved in the regulation of mood, anxiety and sleep. Serotonin helps promote feelings of well-being and tranquility, and its deficiency has been associated with anxiety disorders and depression as well.
​
Ketamine has been found to produce rapid antidepressant effects, even in individuals who have not responded to standard antidepressant medications.
